Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

NY Times' (NYT) Digitization Efforts Help Drive Stock 55% YTD

Published 07/21/2019, 10:07 PM
Updated 07/09/2023, 06:31 AM

The New York Times Company’s (NYSE:NYT) concerted efforts to lower dependency on traditional advertising and focus on digitization have led the shares of this news and information provider to march ahead of the industry. So far in the year, this Zacks Rank #3 (Hold) stock has surged roughly 55.5% compared with the industry’s growth of 34.6%. Industry experts believe that the company’s persistent endeavors to rapidly acclimatize to the changing face of the multiplatform media universe will help the stock to retain momentum.

Changing consumer preferences and innovative technologies have altered the way in which news is offered and consumed. Readers’ preference for accessing news online, mostly free, has made the industry’s print-advertising model increasingly redundant. We note that The New York Times Company’s print advertising revenue fell 11.9% in the first quarter of 2019, following a decline of 10.2% in the preceding quarter.

As readers started thronging the Internet for news, advertisers followed suit, and so did the newspaper companies. Trimmed print operations paved the way for online publications that led to the development of a pay-and-read model, as adopted by The New York Times Company.

A Brief Introspection of NYT

The New York Times Company has been contemplating new avenues of revenue generation in a bid to counter dwindling print advertising revenues. Rapid digitization in the core areas of advertising, subscriptions and sales, printing, and distribution services has turned out to be a major source of revenues.

Notably, the number of paid digital subscribers reached 3,583,000 at the end of first quarter of 2019 — rising 223,000 sequentially and 28.7% year over year. Subscription revenue grew 3.9% principally due to increase in the number of subscriptions to the company’s digital-only products. Revenue from digital-only subscriptions products jumped 15.1%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Management had earlier projected total subscription revenue in the second quarter to increase in the low to mid-single digits, while digital-only subscription revenue likely to rise in the mid-teens. The company has set a goal to reach more than 10 million subscriptions by 2025. The New York Times Company is not only gearing up to become an optimum destination for news and information but is also focusing on service journalism, with verticals like Cooking, Watching and Well.

In this regard, it acquired The Wirecutter and its sister site, The Sweethome that recommends technology gear, home products and other consumer services. The company also acquired a digital marketing agency and portfolio company, HelloSociety, from Science Inc. The buyout complements its T Brand Studio that helps in creating digital ad innovation and branded content. Further, it launched digital subscriptions for NYT Cooking, its popular recipe site and app.

The New York Times Company is diversifying business, adding new revenue streams, strengthening balance sheet and restructuring portfolio. It offloaded assets in order to re-focus on its core newspapers and pay more attention to online activities. Other publishing companies such as New Media Investment Group Inc. (NYSE:NEWM) , Gannett Co., Inc. (NYSE:GCI) and The McClatchy Company (NYSE:MNI) are also trying to adapt to different ways of revenue generation.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119%and +164%in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



The New York Times Company (NYT): Free Stock Analysis Report

Gannett Co., Inc. (GCI): Free Stock Analysis Report

McClatchy Company (The) (MNI): Free Stock Analysis Report

New Media Investment Group Inc. (NEWM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.